Blog Post Describes Experimental Toxic Shock Syndrome Vaccine Research

Bill & Melinda Gates Foundation’s “Impatient Optimists”: Vaccine against Toxic Shock Syndrome successfully tested in a Phase I trial
Melvin Sanicas, global health fellow and program officer with the Gates Foundation, discusses toxic shock syndrome (TSS) and research into an experimental vaccine (6/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.